PHYSICIAN AWARENESS AND INDICATIONS OF 5-ALPHA REDUCTASE INHIBITOR USE FOR BENIGN PROSTATIC HYPERPLASIA IN THE PRIMARY CARE SETTING

被引：0
|
作者：
Loloi, J. [1 ]
Alicea, D. [2 ]
Babar, M. [2 ]
Shah, J. [2 ]
Azhar, U. [2 ]
Labagnara, K. [2 ]
Salam, A. [2 ]
Tang, K. [2 ]
Robles, J. [1 ]
Maria, P. [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2024年 / 21卷
关键词：
D O I：
10.1093/jsxmed/qdae167.213
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
218
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
    Fang, Qinghua
    Chen, Peiya
    Du, Ningchao
    Nandakumar, Kutty Selva
    CLINICAL BREAST CANCER, 2019, 19 (05) : E624 - E636
  • [22] 5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia
    Wallner, Lauren P.
    DiBello, Julia R.
    Li, Bonnie H.
    Van Den Eeden, Stephen K.
    Weinmann, Sheila
    Ritzwoller, Debra P.
    Abell, Jill E.
    D'Agostino, Ralph, Jr.
    Loo, Ronald K.
    Aaronson, David S.
    Richert-Boe, Kathryn
    Horwitz, Ralph I.
    Jacobsen, Steven J.
    MAYO CLINIC PROCEEDINGS, 2016, 91 (12) : 1717 - 1726
  • [23] 5-alpha Reductase Inhibitors and Prostate Cancer Incidence and Mortality among Men with Benign Prostatic Hyperplasia
    Bhaskaran, Krishnan
    Douglas, Ian
    Smeeth, Liam
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 479 - 479
  • [24] THE CLINICAL EFFECTS OF A 5-ALPHA-REDUCTASE INHIBITOR, FINASTERIDE, ON BENIGN PROSTATIC HYPERPLASIA
    STONER, E
    JOURNAL OF UROLOGY, 1992, 147 (05): : 1298 - 1302
  • [25] FINASTERIDE, AN INHIBITOR OF 5-ALPHA-REDUCTASE, SUPPRESSES PROSTATIC DIHYDROTESTOSTERONE IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
    MCCONNELL, JD
    WILSON, JD
    GEORGE, FW
    GELLER, J
    PAPPAS, F
    STONER, E
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (03): : 505 - 508
  • [26] Suicide and Intentional Self-harm Among Older Men Treated With 5-Alpha Reductase Inhibitor or Alpha-blockers for Benign Prostatic Hyperplasia
    Pennap, Dinci
    Mosholder, Andrew D.
    Ajao, Adebola
    Boley, Elena
    Dharmarajan, Sai
    Akhtar, Sandia
    Naik, Kushal B.
    Flowers, Natasha
    Wernecke, Michael
    MaCurdy, Thomas E.
    Kelman, Jeffrey A.
    Graham, David J.
    UROLOGY, 2024, 192 : 111 - 118
  • [27] 5-Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia
    Joseph, Diya B.
    Henry, Gervaise H.
    Malewska, Alicia
    Reese, Jeffrey C.
    Mauck, Ryan J.
    Gahan, Jeffrey C.
    Hutchinson, Ryan C.
    Mohler, James L.
    Roehrborn, Claus G.
    Strand, Douglas W.
    JOURNAL OF PATHOLOGY, 2022, 256 (04): : 427 - 441
  • [28] 5-alpha reductase inhibitors use in prostatic disease and beyond
    Chislett, Bodie
    Chen, David
    Perera, Marlon L.
    Chung, Eric
    Bolton, Damien
    Qu, Liang G.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2023, 12 (03) : 487 - 496
  • [29] Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia: A population-based cohort study
    Doherty, Niamh
    Cardwell, Chris
    Murchie, Peter
    Hill, Christopher
    Azoulay, Laurent
    Hicks, Blanaid
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (04) : 666 - 674
  • [30] Benign prostatic hyperplasia (BPH) management in the primary care setting
    Kapoor, Anil
    CANADIAN JOURNAL OF UROLOGY, 2012, 19 : 10 - 17
12345